Search Results: node
Dendreon Wins Approval for Provenge
Finally, might be the word of the day for the nearly 500 employees of Seattle biotechnology powerhouse Dendreon, which won approval Thursday from the FDA for its therapeutic vaccine Provenge. The treatment is for men with prostate cancer that has not responded to other therapy. The company has spent 15 years working towards this goal….
Enemy of My Enemy
This week’s New Yorker has an execellent article by Ken Auletta that looks at how Apple‘s iPad has taken on Amazon.com‘s Kindle in the e-book space, and what its advent has done for publishers. The takeaway: by opening up the distribution market (via Apple’s iTunes store) and platform, Apple has effectively broken Amazon.com’s initial monopoly…
- « Previous
- 1
- 2
- 3
- 4
Join The Must List
Sign up and get Seattle's best events delivered to your inbox every week.